the effect of nanocurcumin and omega_3 supplement in asthma
Phase 3
- Conditions
- Asthma.Asthma
- Registration Number
- IRCT20191105045340N3
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Patients with asthma diagnosed by a doctor
Asthma patients with an age range of 15 to 60 years
Exclusion Criteria
Users of systemic drugs, NSAIDs, immunosuppressive drugs
NSAID users
Users of immunosuppressive drugs
People with COPD
Cardiovascular patients
Kidney patients
Liver patients
Gastrointestinal patients
Autoimmune patients
suffering from reflexes
Lactating lady
pregnant lady
People addicted to tobacco
Allergy and intolerance to curcumin
Allergy and intolerance to fish oil
Consumption of food supplements and antioxidants from 2 months before and during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life of patients with asthma. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Asthma control questionnaire.;Measurement of airway inflammation in patients with asthma. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Measurement of exhaled nitric oxide through the FeNo device.
- Secondary Outcome Measures
Name Time Method Quality of life questionnaire score of patients with asthma. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Evaluation of the quality of life questionnaire.